Buspirone Hydrochloride

Product NDC: 50090-5762
11-digit product format: 500905762
Labeler code: 50090
Product ID: 50090-5762_60e326e2-6f09-4db0-8656-bce52d20769d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Buspirone Hydrochloride
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA210907
Marketing category: ANDA
Marketing start: 2019-11-14
Marketing end: 0000-00-00
Substance: BUSPIRONE HYDROCHLORIDE
Active strength: 10 mg/1
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50090-5762		D	Discontinued by firm	2026-10-15
excluded package	package	50090-5762	50090-5762-0	D	Discontinued by firm	2026-10-15
excluded package	package	50090-5762	50090-5762-1	D	Discontinued by firm	2026-10-15
excluded package	package	50090-5762	50090-5762-3	D	Discontinued by firm	2026-10-15
excluded package	package	50090-5762	50090-5762-4	D	Discontinued by firm	2026-10-15
excluded package	package	50090-5762	50090-5762-5	D	Discontinued by firm	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-5762-5	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-5762-0	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-5762-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-5762-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-5762-4	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-5762-5	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-5762-0	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-5762-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-5762-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-5762-4	`f5e01cc5f278…`	`a2eaf40c39c3…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210907-001	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14
A210907-002	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14
A210907-003	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14
A210907-004	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A210907-001	AB
A210907-002	AB
A210907-003	AB
A210907-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	RS	2019-11-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB		2019-11-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB		2019-11-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB		2019-11-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2019-11-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-002	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2019-11-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-003	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB		2019-11-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-004	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB		2019-11-14	`2680178bc6a6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	A210907-001	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A210907-002	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A210907-003	AB	1	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A210907-004	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A210907-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210907-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210907-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210907-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A210907-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210907-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210907-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210907-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210907-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210907-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210907-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210907-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210907-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210907-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210907-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210907-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210907-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210907-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210907-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210907-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210907-004	AB	1	`2680178bc6a6…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50090-5762-0	2023-02-07	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-1	2023-02-07	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-3	2023-02-07	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-4	2023-02-07	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-5	2023-02-07	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-0	2023-01-30	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-1	2023-01-30	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-3	2023-01-30	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-4	2023-01-30	Buspirone Hydrochloride Tablets, USP Rx Only
50090-5762-5	2023-01-30	Buspirone Hydrochloride Tablets, USP Rx Only

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-5762-0	EA - Each	50090-5762	75a24a8d-cd69-45e4-8154-b0dcda80bcd7	1	2023-02-06
50090-5762-1	EA - Each	50090-5762	3684b505-d379-49a9-acd2-b633eee76e8c	1	2022-12-07
50090-5762-3	EA - Each	50090-5762	4c9a83be-a5f7-477a-a83e-75307f0e2f65	1	2023-02-06
50090-5762-4	EA - Each	50090-5762	ff8d7ddf-3498-4c1f-baaa-be7c8c07b753	1	2023-02-06
50090-5762-5	EA - Each	50090-5762	5fce9c68-90f2-4f30-849e-9ef3fa805e63	1	2023-02-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-5762	BUSPIRONE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS]	5	Legacy NDC	20231204_365c5457-5dfd-459a-ad8a-ffcbf89d428a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 34 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Bryant Ranch Prepack	20866697-58cd-4639-ae21-2fff486aec81	2025-02-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	fbd7f3fa-11f8-a319-e053-6294a90acae4	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hcl	BUSPIRONE HCL	Direct Rx	da584ae1-4513-6474-e053-2a95a90aac9d	2025-01-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Advanced Rx Pharmacy of Tennessee, LLC	f8afd9b8-0885-2f0c-e053-6294a90a9c57	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	A-S Medication Solutions	932422a8-b72c-4dab-b942-2ab092ed6b01	2024-12-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Bryant Ranch Prepack	38faa7cb-d858-4481-8649-35d228acbd38	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Advanced Rx Pharmacy of Tennessee, LLC	19afb386-72a5-c97e-e063-6294a90adaea	2024-05-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	A-S Medication Solutions	2a25a718-306f-403e-9928-cae30bc52f12	2024-05-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Bryant Ranch Prepack	a2867dde-e5dd-4cc8-84d0-59240626868a	2024-04-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Bryant Ranch Prepack	eab53fff-c052-4466-a673-3d68aab98c27	2024-04-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Bryant Ranch Prepack	5fa0720f-e236-4b8b-a0c0-6f48037c76b3	2024-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Proficient Rx LP	1886b672-4b88-4b49-ae6a-d2ba2f452e44	2024-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	A-S Medication Solutions	bce96786-4d9a-460e-8d92-9908ea2af07a	2023-12-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Unichem Pharmaceuticals (USA), Inc.	a6bdf140-075e-445e-a62d-633a4b97f3a8	2023-12-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210907 application number: ANDA210907

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
207LT9J9OC	BUSPIRONE HYDROCHLORIDE	33386-08-2	BUSPIRONE HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-5762-0	50090576200	30 TABLET in 1 BOTTLE (50090-5762-0)	30 tablet	2021-10-04	0000-00-00	No	No	Current
50090-5762-1	50090576201	90 TABLET in 1 BOTTLE (50090-5762-1)	90 tablet	2021-10-04	0000-00-00	No	No	Current
50090-5762-3	50090576203	180 TABLET in 1 BOTTLE (50090-5762-3)	180 tablet	2021-10-04	0000-00-00	No	No	Current
50090-5762-4	50090576204	45 TABLET in 1 BOTTLE (50090-5762-4)	45 tablet	2021-10-04	0000-00-00	No	No	Current
50090-5762-5	50090576205	60 TABLET in 1 BOTTLE (50090-5762-5)	60 tablet	2021-10-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Buspirone Hydrochloride Tablets, USP Rx Only	A-S Medication Solutions	2023-12-03	HUMAN PRESCRIPTION DRUG LABEL	5